Samuel George A. III

Insider profile

Performance

Overall performance
1.4

Performance over holding periods
1.4
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Samuel George A. III's trades of Lineage Cell Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-11-26 2024-11-26 B Purchase
32,202 +18.0%
161.73
US$1,398,638
32,202 +18.0% 161.73 US$1,398,638